Cytogen, Inc. (KOSDAQ: 217330)
South Korea
· Delayed Price · Currency is KRW
6,820.00
+50.00 (0.74%)
Sep 11, 2024, 2:52 PM KST
Cytogen Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 150,951 | 257,276 | 289,471 | 355,717 |
| Market Cap Growth | -41.14% | -11.12% | -18.62% | - |
| Enterprise Value | 112,408 | 266,578 | 284,261 | - |
| Last Close Price | 6750.00 | 13520.00 | 16200.00 | 20400.00 |
| PE Ratio | - | -15.68 | -15.24 | -31.78 |
| PS Ratio | 38.96 | 80.79 | 380.49 | 1022.63 |
| PB Ratio | 2.77 | 4.82 | 51.18 | 15.46 |
| P/FCF Ratio | -20.04 | -25.49 | -41.21 | -55.16 |
| P/OCF Ratio | -21.53 | -33.88 | -45.38 | -68.02 |
| EV/Sales Ratio | 31.63 | 83.71 | 373.65 | - |
| EV/EBITDA Ratio | -13.26 | -26.98 | -27.91 | - |
| EV/EBIT Ratio | -11.35 | -22.61 | -24.72 | - |
| EV/FCF Ratio | -12.19 | -26.42 | -40.47 | - |
| Debt / Equity Ratio | 0.25 | 0.33 | 4.67 | 1.07 |
| Debt / FCF Ratio | -1.48 | -1.74 | -3.76 | -3.82 |
| Asset Turnover | 0.07 | 0.06 | 0.02 | - |
| Inventory Turnover | 19.65 | 29.83 | - | - |
| Quick Ratio | 16.73 | 5.18 | 0.55 | 5.31 |
| Current Ratio | 17.28 | 5.21 | 0.57 | 6.42 |
| Return on Equity (ROE) | -51.04% | -53.45% | -130.97% | - |
| Return on Assets (ROA) | -14.43% | -12.74% | -14.85% | - |
| Return on Capital (ROIC) | -16.48% | -14.31% | -18.03% | - |
| Earnings Yield | -11.46% | -6.13% | -6.48% | -3.06% |
| FCF Yield | -6.11% | -3.92% | -2.43% | -1.81% |
| Buyback Yield / Dilution | -15.25% | -3.54% | -4.24% | - |
| Total Shareholder Return | -15.25% | -3.54% | -4.24% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.